HCST

hematopoietic cell signal transducer

Basic information

Region (hg38): 19:35902529-35904377

Previous symbols: [ "PIK3AP" ]

Links

ENSG00000126264NCBI:10870OMIM:604089HGNC:16977Uniprot:Q9UBK5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HCST gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HCST gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
3
clinvar
3
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 3 0 1

Variants in HCST

This is a list of pathogenic ClinVar variants found in the HCST region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-35902613-T-A not specified Uncertain significance (Dec 11, 2023)3104544
19-35902628-T-C not specified Uncertain significance (Jun 02, 2024)3283668
19-35903786-T-C not specified Uncertain significance (Jun 27, 2022)2351270
19-35903787-G-A not specified Uncertain significance (Mar 06, 2023)2493928
19-35904357-A-AC Benign (Jan 07, 2020)1238245

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HCSTprotein_codingprotein_codingENST00000246551 41898
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.002050.5221257310111257420.0000437
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4834352.90.8130.00000231567
Missense in Polyphen1010.3490.96624109
Synonymous1.031723.30.7280.00000103215
Loss of Function0.16544.370.9151.86e-753

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004310.000431
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000008810.00000879
Middle Eastern0.000.00
South Asian0.00006570.0000653
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transmembrane adapter protein which associates with KLRK1 to form an activation receptor KLRK1-HCST in lymphoid and myeloid cells; this receptor plays a major role in triggering cytotoxicity against target cells expressing cell surface ligands such as MHC class I chain-related MICA and MICB, and UL16-binding proteins (ULBPs); these ligands are up-regulated by stress conditions and pathological state such as viral infection and tumor transformation. Functions as docking site for PI3-kinase PIK3R1 and GRB2. Interaction of ULBPs with KLRK1-HCST triggers calcium mobilization and activation of the PIK3R1, MAP2K/ERK, and JAK2/STAT5 signaling pathways. Both PIK3R1 and GRB2 are required for full KLRK1-HCST-mediated activation and ultimate killing of target cells. In NK cells, KLRK1-HCST signaling directly induces cytotoxicity and enhances cytokine production initiated via DAP12/TYROBP-associated receptors. In T-cells, it provides primarily costimulation for TCR-induced signals. KLRK1-HCST receptor plays a role in immune surveillance against tumors and is required for cytolysis of tumors cells; indeed, melanoma cells that do not express KLRK1 ligands escape from immune surveillance mediated by NK cells. {ECO:0000269|PubMed:10426994, ECO:0000269|PubMed:10528161, ECO:0000269|PubMed:11015446, ECO:0000269|PubMed:11777960, ECO:0000269|PubMed:12740575, ECO:0000269|PubMed:12740576, ECO:0000269|PubMed:16002667, ECO:0000269|PubMed:16339517, ECO:0000269|PubMed:16582911, ECO:0000269|PubMed:18097042}.;
Pathway
Natural killer cell mediated cytotoxicity - Homo sapiens (human);Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System (Consensus)

Recessive Scores

pRec
0.192

Intolerance Scores

loftool
0.515
rvis_EVS
0.64
rvis_percentile_EVS
83.63

Haploinsufficiency Scores

pHI
0.242
hipred
N
hipred_score
0.180
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.659

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Hcst
Phenotype
endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; embryo phenotype; immune system phenotype; skeleton phenotype;

Gene ontology

Biological process
protein phosphorylation;positive regulation of phosphatidylinositol 3-kinase signaling;regulation of immune response
Cellular component
plasma membrane;cell surface;integral component of membrane
Molecular function
signaling receptor binding;protein binding;phosphatidylinositol 3-kinase binding